Head-to-head comparison
Genesis Health vs Vytora Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Genesis Health is a telehealth platform offering compounded semaglutide and tirzepatide injections alongside brand-name Wegovy, Ozempic, and Zepbound.
From $175/mo (lowest dose rung) sema · From $235/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: States served not publicly listed; telehealth coverage unconfirmed for all states
FDAWarning letter issued to Genesis Health International Inc. dba Genesis in February 2026. See the FDA warning-letter database.
Desk Score
Compounded semaglutide at $179 a month or $149 on a 3-month plan, tirzepatide at $249 or $199, plus brand Mounjaro and Zepbound at $1,399 a month — all-inclusive, no membership fee.
$179/mo sema · $249/mo tirz · Verified August 2026
Marked down on: Injectable only — no oral route
Vytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 53/100 (C) for Genesis Health. Genesis Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Genesis Health
53/100
C
Vytora Health
89/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Genesis Health | Vytora Health |
|---|---|---|
| Semaglutide | From $175/molowest dose rung$175/mo (starting dose, compounded) | $179/mo$179/mo month-to-month; $149/mo on a 3-month plan ($447 every 3 months); same price at every dose; compounded injectable |
| Tirzepatide | From $235/molowest dose rung$235/mo (starting dose, compounded) | $249/mo$249/mo month-to-month; $199/mo on a 3-month plan ($599 every 3 months); same price at every dose; compounded injectable |
| Coverage | Not listed on Genesis Health's site (checked July 2026) | All 50 states and DC |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Adults seeking compounded or brand GLP-1s with coaching and annual pricing from $99/mo. | Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account. |
| Desk Score | 53/100C | 89/100B+ |
The verdict
Desk pick — Vytora HealthVytora Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 53/100 (C) for Genesis Health. Genesis Health still holds its ground where its strengths line up with yours.
Choose Genesis Health if…
Adults seeking compounded or brand GLP-1s with coaching and annual pricing from $99/mo.
From $175/mo (lowest dose rung) sema · From $235/mo (lowest dose rung) tirz
FDAWarning letter issued to Genesis Health International Inc. dba Genesis in February 2026. See the FDA warning-letter database.
Choose Vytora Health if…
Someone who wants a low compounded price without prepaying a year, and the option to move to brand tirzepatide on the same account.
$179/mo sema · $249/mo tirz · All 50 states and DC
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Genesis Health · Vytora Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Genesis Health
- CoreAge Rx vs Vytora Health
- Eden vs Genesis Health
- Ondra Health vs Vytora Health
- Genesis Health vs Pallas Health
- Sesame Care vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.